Travere Therapeutics (TVTX) EBIT Margin Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Travere Therapeutics | 4.14 Bn | 4.06 Bn | 102.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,128.00 |
| Dec 31, 2025 | 24,175.00 |
| Sep 30, 2025 | 10,033.00 |
| Jun 30, 2025 | 3,667.00 |
| Mar 31, 2025 | -2,067.00 |
| Dec 31, 2024 | -2,088.00 |
| Sep 30, 2024 | -1,166.00 |
| Jun 30, 2024 | -4,340.00 |
| Mar 31, 2024 | -23,992.00 |
| Dec 31, 2023 | -19,774.00 |
| Sep 30, 2023 | -16,217.00 |
| Jun 30, 2023 | -27,071.00 |
| Mar 31, 2023 | -26,863.00 |
| Dec 31, 2022 | -25,953.00 |
| Sep 30, 2022 | -26,793.00 |
| Jun 30, 2022 | -23,919.00 |
| Mar 31, 2022 | -26,460.00 |
| Dec 31, 2021 | 10,244.00 |
| Sep 30, 2021 | 236.00 |
| Jun 30, 2021 | -3,050.00 |
| Mar 31, 2021 | -7,189.00 |
| Dec 31, 2020 | -18,259.00 |
| Sep 30, 2020 | 3,518.00 |
| Jun 30, 2020 | -1,887.00 |
| Mar 31, 2020 | 1,511.00 |
| Dec 31, 2019 | 7,241.00 |
| Sep 30, 2019 | 18,433.00 |
| Jun 30, 2019 | 21,753.00 |
| Mar 31, 2019 | 7.87 Mn |